Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to van der Steeg: Role of the apolipoprotein B-apolipoprotein AI ratio in cardiovascular risk.... (0.10 sec) 

Role of the apolipoprotein B-apolipoprotein AI ratio in cardiovascular risk assessment: a …

- annals.org [PDF] 
WA van der Steeg, SM Boekholdt, EA Stein, … - Annals of Internal Medicine, 2007 - Am Coll Physicians
Wim A. van der Steeg, MD; S. Matthijs Boekholdt, MD, PhD; Evan A. Stein, MD,
PhD; Karim El-Harchaoui, MD; Erik SG Stroes, MD, PhD; Manjinder S. Sandhu, PhD;
Nicholas J. Wareham, MBBS, PhD; J. Wouter Jukema, MD, PhD; Robert Luben, ...
Cited by 59 - Related articles - BL Direct - All 3 versions

[PDF] Role of the apolipoprotein B/AI ratio in cardiovascular risk assessment


MS Stroes, NJ Wareham, JW Jukema, R Luben … - … Disease Prevention: from Risk Assessment to Novel …, 2007 - dare.uva.nl
Chapter Role of the apolipoprotein B/AI ratio in cardiovascular risk assessment
A case-control analysis in EPIC-Norfolk Wim A. van der Steeg1@, S. Matthijs
Boekholdt1@, Evan E. Stein3, Karim El Harchaoui1, Erik SG Stroes1, ...
Related articles - View as HTML - All 2 versions

Clinical utility of different lipid measures for prediction of coronary heart disease in men …

- uu.se [PDF] 
E Ingelsson, EJ Schaefer, JH Contois, JR … - Jama, 2007 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Evidence is ...
Cited by 121 - Related articles - BL Direct - All 8 versions

Improving prediction of ischemic cardiovascular disease in the general population using …

- ahajournals.org
M Benn, B Nordestgaard, GB Jensen, A … - Arteriosclerosis, thrombosis, and vascular biology, 2007 - Am Heart Assoc
Methods and Results— We studied 9231 asymptomatic women and men from the
Danish general population followed prospectively for 8 years and observed the
following incident events: ischemic heart disease 591, myocardial ...
Cited by 32 - Related articles - All 7 versions

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of …


PJ Barter, CM Ballantyne, R Carmena, MC … - Journal of internal medicine, 2006 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 143 - Related articles - BL Direct - All 7 versions

The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for …

- pubget.com [PDF] 
G Walldius, I Jungner - Journal of internal medicine, 2006 - pt.wkhealth.com
Correspondence: Göran Walldius, Astra Zeneca (ISMO), SE-151 85 Södertälje,
Sweden. (fax: +46 (0) 8 553 23157; e-mail: goran.walldius@astrazeneca.com). ...
The rationale for using apoB, apoA-I and the apoB...
Cited by 115 - Related articles - BL Direct - All 8 versions

Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary …

- ahajournals.org
T Pischon, CJ Girman, FM Sacks, N Rifai, MJ … - Circulation, 2005 - Am Heart Assoc
From the Departments of Nutrition (TP, FMS, MJS, EBR) and Epidemiology (TP, MJS,
EBR), Harvard School of Public Health, Boston, Mass; Channing Laboratory (FMS,
MJS, EBR), Department of Medicine, Brigham and Women's Hospital, Harvard ...
Cited by 156 - Related articles - All 7 versions

The role of global risk assessment in hypertension therapy


SA Grover, B Hemmelgarn, L Joseph, A Milot, … - The Canadian journal of cardiology, 2006 - pubmedcentral.nih.gov
To maximize the benefits of preventive therapy, lipid and hypertension
guidelines increasingly recommend that high-risk individuals be targeted for
treatment. An individual's risk of developing cardiovascular disease ...
Cited by 16 - Related articles - All 4 versions

Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older …


R Clarke, JR Emberson, S Parish, A Palmer, M … - Archives of Internal Medicine, 2007 - archinte.highwire.org
Methods We assessed IHD mortality associations with plasma levels of total
cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein
cholesterol, apolipoprotein B, and apolipoprotein A 1 measured in older ...
Cited by 17 - Related articles - BL Direct - All 5 versions

Value of Low-Density Lipoprotein Particle Number and Size as Predictors of Coronary …

- onlinejacc.org
K El Harchaoui, WA van der Steeg, ESG … - Journal of the American College of Cardiology, 2007 - Elsevier
A nested case-control study was performed in the prospective EPIC (European
Prospective Investigation into Cancer and Nutrition)-Norfolk study, which
comprises 25,663 subjects. Cases (n = 1,003) were individuals who developed ...
Cited by 50 - Related articles - BL Direct - All 23 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google